Susan E. Graf
Director · Aardvark Therapeutics, Inc.
- 2024
- Aug 21, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Susan E. Graf files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nelson Sun - $438K in AARD purchases and sales in the last 12 months
- Tien-Li Lee - $101K in AARD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Susan E. Graf?
Susan E. Graf is a corporate insider, tracked as Director of Aardvark Therapeutics, Inc. (AARD). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Susan E. Graf submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.